117 results on '"Risi E"'
Search Results
2. 148P Serum metabolomics based risk assessment of disease recurrence in elderly patients with early breast cancer (eBC)
3. Bactériologie des otites moyennes chez le lapin : étude rétrospective de 18 cas traités chirurgicalement
4. 1883P Impact of geriatrician-implemented Interventions on chemotherapy (CT) delivery in vulnerable elderly patients with early or advanced solid tumors: The GIVE trial.
5. 2272P Minimal DNA-methylation (DNAm) signatures for non-invasive tumor-agnostic estimation of tumor content (TC) and molecular subtype in patients (pts) with metastatic breast cancer (mBC)
6. 8P Mutational analysis of circulating tumour DNA (ctDNA) in patients with ER+/HER2- advanced breast cancer (ABC) receiving palbociclib (P): Results from the TREnd trial
7. 6P Circulating tumour cells (CTCs) as biomarkers of resistance to the CDK4/6 inhibitor (CDK4/6i) palbociclib (P) in patients (pts) with ER+/HER2-negative advanced breast cancer (ABC)
8. Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen receptor & HER2 positive (ER+/HER2+) breast cancer (BC) (International Breast Cancer Study Group IBCSG 55-17, TOUCH)
9. SIOG2022-0056 - Risk assessment of Disease Recurrence (DR) through serum metabolomics analysis in elderly patients (pts) with early breast cancer (eBC)
10. Abstract P6-09-02: Effects of palbociclib on thymidine kinase-1 (TK1) in hormone receptor positive (HR+) breast cancer cell lines
11. Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial
12. 286TiP - Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen receptor & HER2 positive (ER+/HER2+) breast cancer (BC) (International Breast Cancer Study Group IBCSG 55-17, TOUCH)
13. Gene signatures as potential predictive markers of response to neoadjuvant chemotherapy in ER+/HER2+ breast cancer patients
14. No pain, no gain… What we can learn from a trial reporting negative results
15. Abstract P1-09-13: A RB-1 loss-of-function gene-signature (RBsig) predicts resistance to neoadjuvant chemotherapy in HER2+/ER+ breast cancer patients
16. Serum metabolomic profiles identify ER-positive early breast cancer patients at increased risk of disease recurrence in a multicentre population
17. A single centre pilot study aiming to determine the recommended dose (RD) of metronomic oral vinorelbine in combination with oral cyclophosphamide and bevacizumab in advanced breast cancer (ABC) patients
18. Does body mass index impact on clinical outcomes in her-2 positive metastatic breast cancer?
19. First line trastuzumab-based therapy in her2-positive metastatic breast cancer patients presenting with de novo or recurrent disease
20. First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab
21. Abcès buccal par corps étranger chez un chinchilla
22. Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study)
23. 1861 Body mass index and prognosis in HER2-positive metastatic breast cancer patients
24. 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab
25. PEMETREXED-RELATED RENAL TOXICITY IN PATIENTS (PTS) WITH THORACIC MALIGNANCIES
26. Genetica dell’atopia
27. 95P - Gene signatures as potential predictive markers of response to neoadjuvant chemotherapy in ER+/HER2+ breast cancer patients
28. Autonomic dysfunction with postural hypotension and parasympathetic prevalence in Sjögren’s syndrome
29. Detection of circulating serum galactomannan for the diagnosis of avian aspergillosis
30. Objectifs et mission d’un réseau de vétérinaires pour la faune sauvage
31. Comparison of two serological tests for the diagnosis of aspergillosis in birds
32. Treatment (T) of Metastatic Colorectal Cancer (Mcrc) Patients (Pts) ≥75 Years (Y) Old in Clinical Practice: a Multicenter Analysis
33. Control of Reproduction in Ferrets, Rabbits and Rodents
34. Traitement des plaies du bréchet de canards marins hospitalisés en centre de soins de la faune sauvage
35. F47 - A single centre pilot study aiming to determine the recommended dose (RD) of metronomic oral vinorelbine in combination with oral cyclophosphamide and bevacizumab in advanced breast cancer (ABC) patients
36. Chemotherapy is Effective in Primitive Neuroectodermal Tumor (PNET) / Ewing Sarcoma (EWS) of The Kidney
37. Gene expression profile of circulating tumor cells (CTCs) in clear cell metastatic renal cell carcinoma (mRCC).
38. High-Grade Mucoepidermoid Carcinoma of the Mandibular Salivary Gland in a Lion (Panthera leo)
39. Churg-Strauss Syndrome Development during Asthma Therapy with Leukotriene Receptor Antagonists: Just a Coincidental Association?
40. 600P - Treatment (T) of Metastatic Colorectal Cancer (Mcrc) Patients (Pts) ≥75 Years (Y) Old in Clinical Practice: a Multicenter Analysis
41. Boltzmann master equation theory of angular distributions in heavy-ion reactions
42. Ejectile angular distributions in Boltzmann master equation theory of nuclear reactions
43. Ricovero distrettuale per i vecchi
44. PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
45. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence
46. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting
47. Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial
48. Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis
49. L'adozione dei nuovi media da parte degli anziani: un'opportunità da cogliere e da comunicare
50. Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.